Croda Cuts Forecasts: What’s Really Going On?
Croda International, the FTSE listed speciality chemicals group, has officially backed a lower full year outlook for 2025. After a difficult 2024 filled with inventory corrections and weakening demand in consumer and crop care, Croda’s muted tone is no great shock to the market. Still, its shares have underperformed significantly, now sitting around 40% below their post pandemic highs.
What’s Pressuring Croda in 2025?
Croda’s main pain points lie in sluggish demand across two major divisions:
- Consumer Care: Personal care and beauty brands have been destocking for over a year.
- Crop Protection: Farmers and distributors are delaying purchases in a volatile agri market.
While the company’s Life Sciences division continues to show resilience particularly in pharmaceutical ingredients it hasn’t been enough to offset weakness elsewhere.
Croda’s recent trading update reaffirmed that revenue and margins will remain under pressure through the second half of 2025.
Dividend Still Intact For Now
Despite the cautious outlook, Croda’s dividend yield sits around 2.8%, with a payout ratio still within a sustainable band. The company has a strong balance sheet, robust free cash flow, and a long history of capital discipline.
However, if margin pressure persists and sales continue sliding, dividend growth could flatten or worse, stall.
For income focused investors, this is a yellow flag, not a red one yet.
Is This Just a Downcycle?
Let’s zoom out. Croda isn’t a cyclical oil refiner it’s a specialist, high margin chemical producer that sells to defensible end markets like pharma, beauty, and agriculture.
The company is still investing heavily in plant based innovation, biotech fermentation, and sustainable materials. These aren’t short-term wins but they position Croda well for the decade ahead.
That makes this downturn feel cyclical rather than structural. If you’re patient, this could be the kind of moment long term investors look for.
Know What You’re Buying
Croda’s share price slump looks tempting but it’s not a slam dunk.
If you’re a long-term, fundamentals first investor, there’s a case to be made here. A strong brand, defensive markets, and ESG aligned innovation keep Croda relevant.
But if you’re hunting short term momentum or dividend growth, this could feel more like dead money until at least mid 2026.
Content on IceburgWealth.com is for informational purposes only and not intended as investment advice. While we strive to provide accurate and up-to-date information, Iceburg Wealth is not responsible for any errors or omissions, or for outcomes resulting from the use of this information. Readers should seek professional advice before making any financial decisions.